CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

COVID 19 diagnostic test by PCRWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug669 Questionnaire by phone call Wiki 1.00

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D012859 Sjogren's Syndrome NIH 1.00
D015535 Arthritis, Psoriatic NIH 0.71
D001327 Autoimmune Diseases NIH 0.71
D001168 Arthritis NIH 0.58
D008180 Lupus Erythematosus, Systemic NIH 0.58

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic by Creation and Analysis of a Biological and Tissue Collection of Pregnancy Outcomes

A new coronavirus (COVID-19) highlighted at the end of 2019 in China is spreading across all continents. Most often at the origin of a mild infectious syndrome, associating benign symptoms (such as fever, cough, and headache) to different degrees, COVID-19 can cause serious pulmonary pathologies and sometimes death. Data on the consequences during pregnancy are limited. The first Chinese data published seem to show that the symptoms in pregnant women are the same as those of the general population. There are no cases of intrauterine maternal-fetal transmission, but cases of newborns infected early suggest that there could be vertical intrauterine, perpartum or neonatal transmission. Prematurity and cases of respiratory distress in newborns of infected mothers have been described. Subsequently, an in-depth analysis of cases in pregnant women and pregnancy issues are necessary in order to improve knowledge on the subject.

NCT04360811 Pregnancy Diagnostic Test: COVID 19 diagnostic test by PCR

Primary Outcomes

Description: Exposure to SARS-CoV-2 will be measured the day of delivery by RT-PCR on maternal saliva and by serology on maternal blood

Measure: number of positive COVID-19 women

Time: Day 0

Secondary Outcomes

Description: Description of the number of positive COVID-19 RT-PCRs in the conception products: amniotic fluid, frozen placenta fragment, frozen fetal tissue, cord blood or frozen cord fragment

Measure: number of positive COVID-19 women

Time: Day 0

No related HPO nodes (Using clinical trials)